Inside the Body's journey: tracing MK-5475 from entry to exit
NCT ID NCT06777602
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 30 times
Summary
This completed early-stage study involved 8 healthy men to learn how the investigational drug MK-5475 is absorbed, broken down, and removed from the body. Participants received a single intravenous dose containing a radioactive tracer to track the drug's path. The study did not aim to treat any disease, but to gather essential safety and processing data for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Labcorp Clinical Research Unit Inc. (Site 0001)
Madison, Wisconsin, 53704, United States
Conditions
Explore the condition pages connected to this study.